Jennifer Bryant is a project director with 20 years of experience in leading globally based on-site and remote teams in the administration of complex, interdisciplinary HIV/AIDS and gene therapy clinical trials. She excels in managing multisite networks for clinical centers, conducting site qualification and readiness visits, negotiating contracts, initiating protocols, and overseeing site activities to ensure compliance with study protocols. Ms. Bryant promotes full-service client relationships by serving as the primary point of contact, preparing performance metrics and progress reports, developing cost-conscious budgets, supervising and coordinating the work of staff, and ensuring that all deliverables are of high quality and on time.
At Westat, Ms. Bryant has served as the project director for the NICHD International and Domestic Pediatric and Maternal HIV and Other Infectious Diseases Data Coordinating Center and under that contract, she partnered with an expert in pre-clinical models of HIV antiretroviral safety in pregnancy for an International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) study.
In former positions, Ms. Bryant served as a clinical trial manager and clinical lead for other contract research organizations. In these roles, she managed the site monitoring for the first directly administered U.S. Food and Drug Administration-approved gene therapy project targeting a disease caused by mutations in a specific gene as well as supported COVID vaccine, infectious diseases, and ophthalmology clinical trials. She is a Certified Clinical Research Professional through SOCRA and currently is on the Board of Directors.
BA, Political Science/English, University of Nebraska – Lincoln
MPA, Public Administration, University of Illinois – Springfield